U.S. Insurance Stock News

Archrock Inc. (NYSE:AROC) has announced the planned retirement of its long-serving Chief Financial Officer, Douglas S. Aron. The company has begun a formal search process to identify and appoint a new CFO. Aron will continue in his role during the transition period to support continuity in financial leadership. Archrock, a contract compression services provider to the U.S. energy industry, depends heavily on steady capital allocation, balance sheet management and long term contract...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Franklin...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...

Intellicheck, Inc. ( NASDAQ:IDN ) recently posted some strong earnings, and the market responded positively. We did...

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.

Readers hoping to buy Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) for its dividend will need to make their move shortly...

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...

SIGA Technologies (NasdaqGM:SIGA) has declared a special cash dividend for its shareholders. The announcement provides a direct cash return in addition to any regular dividend policy the company may have. The timing of the dividend decision highlights management's current view of the company’s cash position and capital needs. SIGA Technologies focuses on health security solutions, including products designed for infectious disease and biodefense settings. A special cash dividend draws...

We feel now is a pretty good time to analyse Prothena Corporation plc's ( NASDAQ:PRTA ) business as it appears the...

We wouldn't blame Best Buy Co., Inc. ( NYSE:BBY ) shareholders if they were a little worried about the fact that Corie...

NextDecade Corporation ( NASDAQ:NEXT ) shareholders (or potential shareholders) will be happy to see that insider...

Republic Bancorp, Inc. (NasdaqGS:RBCA.A) has been added to the S&P Regional Banks Select Industry Index. The inclusion places the company alongside a peer group of publicly traded regional banks tracked by institutional and index investors. Republic Bancorp operates as a regional banking company, with its core business centered on traditional lending, deposits, and related financial services. Inclusion in the S&P Regional Banks Select Industry Index can draw more attention from...

Bio-Techne, ticker NasdaqGS:TECH, has expanded its COMET spatial biology workflow with new SPYRE Focus Panels and Amplification Kits. The company has also released upgrades to its HORIZON Image Analysis Software to support more advanced tissue analysis. The updates aim to give researchers greater flexibility, sensitivity, and throughput in preclinical and translational studies. Bio-Techne is adding this product expansion at a time when the share price is around $52.70, with the stock down...

If you are wondering whether Adeia's share price still reflects fair value after its recent run, this breakdown will help you separate price from worth. The stock last closed at US$24.36, with returns of 3.9% over 7 days, 23.3% over 30 days, 38.6% year to date and 76.7% over the past year, providing context for any valuation check. Recent coverage has focused on Adeia's role as a software company and the way investors are reacting to its business model and positioning. This backdrop helps...

Penske Automotive Group (NYSE:PAG) has completed the sale of Lexus of Warwick in Rhode Island. The buyer is the McGee Automotive Family, which plans to continue operating the dealership as a Lexus store. The transaction marks a change in Penske Automotive Group's dealer portfolio and geographic mix. Penske Automotive Group (NYSE:PAG) is a diversified transportation services company with a large network of franchised dealerships. The sale of Lexus of Warwick fits into a broader pattern of...

Health In Tech (HIT) has put up another busy quarter in FY 2025, with Q3 revenue of about US$8.5 million and basic EPS of US$0.008, set against a year where revenue was 55.1% higher and trailing net profit margins sat at 4.7% compared with 9.2% a year earlier. Over recent periods the company has seen quarterly revenue move from about US$5.0 million in Q2 2024 to US$4.9 million in Q4 2024, then to US$8.0 million in Q1 2025, US$9.3 million in Q2 2025 and US$8.5 million in Q3 2025. Over the same...

United Guardian (OTCPK:UTGN) has wrapped up FY 2025 with a mixed set of numbers, as Q4 revenue came in at a slight loss of US$0.3 million and net income swung to a loss of US$4.2 million, against a backdrop where trailing 12 month revenue sits at US$42.3 million and net income at US$17.1 million. Over recent quarters the company has seen revenue move from US$16.2 million and EPS of US$2.33 in Q4 2024 to US$21.9 million and EPS of US$4.05 in Q1 2025, before settling at US$17.3 million and EPS...

Marblegate Capital (OTCPK:MGTE) has just posted its FY 2025 numbers, reporting Q3 revenue of US$12.0 million and a basic EPS loss of US$0.02. This is set against a trailing 12 month revenue base of US$10.3 million and a basic EPS loss of US$0.91 that reflects the broader year. Over recent quarters, the company’s revenue has moved from US$5.1 million in Q2 2024 to US$5.4 million in Q3 2024 and then to US$4.6 million, US$9.7 million and US$12.0 million in Q1, Q2 and Q3 2025 respectively. EPS...

First National (FXNC) has reported FY 2025 results with fourth quarter revenue of US$23.0 million and EPS of US$0.61, capping a trailing twelve month revenue line of US$87.0 million and EPS of US$1.97 that reflects 154.1% earnings growth over the past year. Over recent periods, revenue has moved from US$13.3 million in Q3 2024 to US$17.1 million in Q4 2024 and then to US$23.0 million in Q4 2025. Quarterly EPS shifted from a loss of US$0.10 in Q4 2024 to US$0.61 in Q4 2025, highlighting a...

KalVista Pharmaceuticals (KALV) closed FY 2025 with fourth quarter revenue of US$59.9 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$5.4 million loss. This provides a clear snapshot of a business still in investment mode. The company has seen quarterly revenue shift from US$13.7 million in FY 2025 Q3 to US$59.9 million in FY 2025 Q4, while basic EPS moved from a US$0.92 loss to a US$0.10 loss over the same period, highlighting a set of results...